As a new treatment for malignant tumors, highly specific targeted drugs have been vigorously promoted in modern medical cancer treatment. At present, the problems of large single dose, high quality standard and high cost of targeted drugs have become well-known rich drugs. Accurate IC50 prediction of targeted drugs has important practical significance for cancer economy and precision treatment. In this paper, 179 groups of characteristic parameters of targeted drugs against hepatoma cell line from Genomics of Drug Sensitivity in Cancer (GDSC) open source database are selected as model input. Half maximal inhibitor concentration (IC50) of targeted drug action is used as model output. Then, IC50 prediction model based on SSA-BP neural network is established. Compared with other methods, the proposed model has faster convergence speed and higher prediction accuracy, and the overall regression coefficient is 0.96463.